Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
Vivian Bykerk, BSc, MD, from Hospital for Special Surgery, answers our questions on new research about the impact of HLA-DRB1 risk alleles on the clinical efficacy of 2 biologic agents for the management of...
Vanessa Kronzer, MD, from the Mayo Clinic, answers our questions about her study that assessed the association between rheumatoid arthritis, asthma, passive smoke exposure, and more.
William G. Dixon, MRCP, MSc, PhD, answers our questions about remote monitoring of RA and how it may improve the collection of patient-generated health data to benefit the overall management of RA.
A new analysis of the ArthritisPower registry aimed to identify factors that patients believe influenced their physician’s treatment decisions. Lead authors W. Benjamin Nowell, PhD, and Kelly Gavigan, MPH,...
Jeffrey Ruth, PhD, from the University of Michigan Medical School, answers our questions about his research on the role of inhibitor of DNA binding 1 protein in rheumatoid arthritis.
Jeffrey Ruth, PhD, from the University of Michigan Medical School, answers our questions about his research on the role of inhibitor of DNA binding 1 protein in rheumatoid arthritis.
Michael Ward, MD, PhD, from the National Institutes of Health, answers our questions about his research that measured minimal clinically important improvement of the Routine Assessment of Patient Index Data...
